Radiographic and Histological Analysis of a Synthetic Bone Graft Substitute Eluting Gentamicin in the Treatment of Chronic Osteomyelitis

Ferguson, Jamie; Athanasou, Nicholas; Diefenbeck, Michael; McNally, Martin

doi:https://doi.org/10.7150/jbji.31592

Articles | Volume 4, issue 2

Article
Metrics
Related articles

Articles | Volume 4, issue 2

https://doi.org/10.7150/jbji.31592

Articles | Volume 4, issue 2

Article
Metrics
Related articles

Original full-length article

16 Mar 2019

Original full-length article |

| 16 Mar 2019

Radiographic and Histological Analysis of a Synthetic Bone Graft Substitute Eluting Gentamicin in the Treatment of Chronic Osteomyelitis

Jamie Ferguson, Nicholas Athanasou, Michael Diefenbeck, and Martin McNally

Jamie Ferguson

Consultant in Limb Reconstruction and Trauma Surgery, Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Nicholas Athanasou

Professor of Musculoskeletal Pathology, Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Michael Diefenbeck

Honorary Consultant Orthopaedic Surgeon, Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Martin McNally

Consultant in Limb Reconstruction Surgery, Honorary Senior Lecturer in Orthopaedic Surgery, Bone Infection Unit, Nuffield Orthopaedic Centre, Oxford Radcliffe Hospitals NHS Foundation Trust, Oxford, UK

Cited articles

Cierny G, Mader JT, Penninck JJ. The classic: A clinical staging system for adult osteomyelitis. Clinical Orthopaedics & Related Research. 2003;414:7–24.

McNally M, Nagarajah K. Osteomyelitis. Orthopaedics and Trauma. 2010;24(6):416–29. [Google Scholar]

Walenkamp GH, Vree TOMB, Van Rens TJ. Gentamicin-PMMA beads: Pharmacokinetic and nephrotoxicological study. Clinical Orthopaedics & Related Research. 1986;205:171–83.

Ferguson J, Diefenbeck M, McNally M. Ceramic biocomposites as biodegradable antibiotic carriers in the treatment of bone infections. J Bone Jt Infect. 2017;2(1):38–51. [PMC free article]

Dressmann H. Über Knochenplombierung bei höhlenformigen Defekten des Knochens. Beitr Klin Chir. 1892;9:804–810. [Google Scholar]

Peltier LF. The use of plaster of Paris to fill large defects in bone. Am J Surg. 1959;97:311–315.

Turner TM, Urban RM, Gitelis S, Kuo KN, Andersson GB. Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery: one institution's experience. J Bone Joint Surg Am; 2001. p. 83. -A Suppl 2(Pt 1):8-18.

Ferguson JY, Dudareva M, Riley ND, Stubbs D, Atkins BL, McNally MA. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J; 2014. p. 96. -B: 829-836.

Kopylov P, Jonsson K, Thorngren KG, Aspenberg P. Injectable calcium phosphate in the treatment of distal radial fractures. J Hand Surg Br. 1996;21:768–771.

Keating JF, Hajducka CL, Harper J. Minimal internal fixation and calcium-phosphate cement in the treatment of fractures of the tibial plateau. A pilot study. J Bone Joint Surg Br. 2003;85:68–73.

Jubel A, Andermahr J, Mairhofer J, Prokop A, Hahn U, Rehm KE. Use of the injectable bone cement Norian SRS for tibial plateau fractures. Results of a prospective 30-month follow-up study. Orthopäde. 2004 Aug;33:919–927.

Nilsson M, Wang JS, Wielanek L, Tanner KE, Lidgren L. Biodegradation and biocompatability of a calcium sulphate-hydroxyapatite bone substitute. J Bone Joint Surg Br. 2004;86:120–125.

Nilsson M, Zheng MH, Tägil M. The composite of hydroxyapatite and calcium sulphate: a review of preclinical evaluation and clinical applications. Expert Rev Med Devices. 2013;10:675–684.

Abramo A, Geijer M, Kopylov P, Tägil M. Osteotomy of distal radius fracture malunion using a fast remodeling bone substitute consisting of calcium sulphate and calcium phosphate. J Biomed Mater Res B Appl Biomater. 2010;92:281–286.

Iundusi R, Gasbarra E, D'Arienzo M, Piccioli A, Tarantino U. Augmentation of tibial plateau fractures with an injectable bone substitute: CERAMENT™. Three year follow-up from a prospective study. BMC Musculoskelet Disord. 2015;16:115. [PMC free article]

Kaczmarczyk J, Sowinski P, Goch M, Katulska K. Complete twelve month bone remodelling with a bi-phasic injectable bone substitute in benign bone tumours: a prospective pilot study. BMC Musculoskel. Disord. 2015;16:369. [PMC free article]

Dvorzhinskiy A, Perino G, Chojnowski R, Van Der Meulen M, Ross F, Bostrom M, Yang X. Cerament bone void filler with gentamicin increases bone formation and decreases detectable infection in a rat model of debrided osteomyelitis. Bone Joint J; 2015. p. 97. -B, Suppl.16:9. [Google Scholar]

Stravinskas M, Horstmann P, Ferguson J, Hettwer W, Nilsson M, Tarasevicius S Petersen M, McNally M, Lidgren L. Pharmacokinetics of gentamicin eluted from a regenerating bone graft, substitute: In vitro and clinical release studies. Bone Joint Res; 2016. Sep;5(9):427-35. [PMC free article]

McNally MA, Ferguson JY, Lau AC, Diefenbeck M, Scarborough M, Ramsden AJ, Atkins BL. Single-stage treatment of chronic osteomyelitis with a new absorbable, gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite: a prospective series of 100 cases. Bone Joint J. 2016;98(9):1289–96.

Yamamoto T, Onga T, Marui T, Mizuno K. Use of hydroxyapatite to fill cavities after excision of benign bone tumours. Clinical results. J Bone Joint Surg Br. 2000;82:1117–1120.

Matsumine A, Myoui A, Kusuzaki K, Araki N, Seto M, Yoshikawa H, Uchida A. Calcium hydroxyapatite ceramic implants in bone tumour surgery. A long-term follow-up study. J Bone Joint Surg Br. 2004;86:719–725.

Hattori H, Matsuoka H, Yamamoto K. Radiological and histological analysis of synthetic bone grafts in recurring giant cell tumour of bone: a retrospective study. J Orthop Surg (Hong Kong) 2010;18:63–67.

Meyer S, Floerkemeier T, Windhagen H. Histological osseointegration of a calcium phosphate bone substitute material in patients. Biomed Mater Eng. 2007;17:347–356.

McNally M, Ferguson J, Kugan R, Stubbs D. Ilizarov treatment protocols in the management of infected non-union of the tibia. J Orthop Trauma. 2007 Oct;31(Suppl 5):S47–54.

Spangehl MJ, Masri BA, O'Connell JX, Duncan CP. Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg [Am]; 1999. p. 81. -A:672-683.

Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto TE, McLardy-Smith P, Berendt AR, OSIRIS Collaborative Study Group. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol. 1998;36:2932–2939. [PMC free article]

Sheehy SH, Atkins BA, Bejon P, Byren I, Wyllie D, Athanasou NA, Berendt AR, McNally MA. The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. J Infect. 2010;60:338–343.

Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.

Kashima TG, Dongre A, Opperman U, Athanasou NA. Dentine matrix protein 1 is a marker of bone-forming tumours. Virchows Archiv. 2013;462:583–591.

Maggiani F, Forsyth R, Hogendoorn PCW, Krenacs T, Athanasou NA. Immunophenotype of osteoclasts and macrophage polykaryons. J Clin Pathol. 2011;64:701–5.

Athanasou NA, Quinn J. Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol. 1990;43:997–1004. [PMC free article]

McKee MD, Wild LM, Schemitsch EH, Waddell JP. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: Early results of a prospective trial. J Orthop Trauma. 2002;16:622–627.

McKee MD, Li-Bland EA, Wild LM, Schemitsch EH. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. J Orthop Trauma. 2010;24:483–90.

Cierny G 3rd, DiPasquale D. Treatment of chronic infection. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S105–110.

Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg [Am] 2004;86:2305–2318.

Xie Z, Liu X, Jia W, Zhang C, Huang W, Wang J. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. J Control Release. 2009;139:118–126.

Turner TM, Urban RM, Hall DJ, Chye PC, Segreti J, Gitelis S. Local and systemic levels of tobramycin delivered from calcium sulfate bone graft substitute pellets. Clin Orthop Relat Res. 2005;437:97–104.

Romanò CL, Logoluso N, Meani E, Romanò D, De Vecchi E, Vassena C, Drago L. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis a retrospective comparative study. Bone Joint J. 2014;96:845–850.

Kanakaris N, Gudipati S, Tosounidis T, Harwood P, Britten S, Giannoudis PV. The treatment of intramedullary osteomyelitis of the femur and tibia using the reamer-irrigator-aspirator system and antibiotic cement rods. Bone Joint J. 2014;96:783–8.

Fleiter N, Walter G, Bösebeck H, Vogt S, Büchner H, Hirschberger W, Hoffmann R. Clinical use and safety of a novel gentamicin-releasing resorbable bone graft substitute in the treatment of osteomyelitis/osteitis. Bone Joint Res. 2014;3:223–229. [PMC free article]

Kotnis NA, Parasu N, Finlay K, Jurriaans E, Ghert M. Chronology of the radiographic appearances of the calcium sulphate-calcium phosphate synthetic bone graft composite following resection of bone tumours-a preliminary study of the normal post-operative appearances. Skeletal Radiol. 2011;40:563–570.

Tan V, Evaniew N, Finlay K, Jurriaans E, Ghert M, Deheshi B, Parasu N. Chronology of the Radiographic Appearances of the Calcium Sulfate-Calcium Phosphate Synthetic Bone Graft Composite Following Resection of Bone Tumors: A Follow-up Study of Postoperative Appearances. Can Assoc Radiol J. 2016;67:21–27.

Beaman FD, Bancroft LW, Peterson JJ, Kransdorf MJ, Menke DM, DeOrio JK. Imaging characteristics of bone graft materials. Radiographics. 2006;26:373–388.

Hettwer W, Horstmann P, Bischoff S, Güllmar D, Reichenbach J, Poh P, van Griensven M, Gras F, Diefenbeck M. Establishment and effects of allograft and synthetic bone graft substitute treatment of a critical size metaphyseal bone defect model in the sheep femur. APMIS. 2019;127:53–63. [PMC free article]